Screener
Summit Therapeutics SMMT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 17,551 | 6,537 |
| Total current assets | 616,598 | 720,301 |
| Non-current assets: | ||
| Property and equipment, net | 1,664 | 1,059 |
| Operating lease right-of-use assets | 19,398 | 20,616 |
| Goodwill | 1,965 | 2,001 |
| Other assets | 8,231 | 7,205 |
| Total assets | $647,856 | $751,182 |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's PP&E (net)?
- Summit Therapeutics (SMMT) reported PP&E (net) of $1.66M in Q1 2026.
- How has Summit Therapeutics's PP&E (net) changed year-over-year?
- Summit Therapeutics's PP&E (net) increased by 155.2% year-over-year, from $652K to $1.66M.
- What is the long-term trend for Summit Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Summit Therapeutics's PP&E (net) has grown at a 7.9% compound annual growth rate (CAGR), from $725K to $1.06M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Summit Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude